Silver Nanoparticles with Bronchodilators Through Nebulisation to Treat COVID 19 Patients.
Subhasish Sarkar
Abstract
There are no effective antiviral drugs available against the pandemic causing COVID 19 virus. The complex protein - protein interaction between the virus and host is yet to be determined for designing of precise antiviral drugs against corona virus. The pandemic had claimed several thousand lives and had resulted most devastating effects on our mankind. In this scenario a potent drug is needed which will kill the viruses with minimal side effects on human body. Here I propose a novel antiviral therapy for effective killing of COVID19 with minimal side effects.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicVirusVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrugMedicineBiologyPharmacologyInfectious disease (medical specialty)DiseaseInternal medicineOutbreakNanoparticles: synthesis and applicationsGraphene and Nanomaterials ApplicationsInhalation and Respiratory Drug Delivery